MERCK SHARP & DOHME CORP. et al v. MYLAN PHARMACEUTICALS INC. et al
Case Number:
2:09-cv-06383
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 27, 2012
Merck Defeats Mylan's Challenge To Zetia, Vytorin Patent
A Merck & Co. Inc. unit prevailed Friday in a patent suit against Mylan Pharmaceuticals Inc. over its generic versions of cholesterol drugs Zetia and Vytorin, with a New Jersey federal judge ruling valid Merck's patent on an active ingredient of the drugs.
-
May 19, 2011
CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit
Schering Corp. on Tuesday won the dismissal of an inequitable conduct counterclaim by Mylan Pharmaceuticals Inc. in a ruling in Schering's lawsuit accusing the generic-drug maker of infringing its patents on cholesterol drug Vytorin. (A previous version of this article incorrectly stated that a ruling had been made on Mylan's antitrust counterclaims.)